BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 10852543)

  • 1. Clinical and biochemical characteristics of congenital disorder of glycosylation type Ic, the first recognized endoplasmic reticulum defect in N-glycan synthesis.
    Grünewald S; Imbach T; Huijben K; Rubio-Gozalbo ME; Verrips A; de Klerk JB; Stroink H; de Rijk-van Andel JF; Van Hove JL; Wendel U; Matthijs G; Hennet T; Jaeken J; Wevers RA
    Ann Neurol; 2000 Jun; 47(6):776-81. PubMed ID: 10852543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital disorder of glycosylation-Ic: case report and genetic defect.
    Hanefeld F; Körner C; Holzbach-Eberle U; von Figura K
    Neuropediatrics; 2000 Apr; 31(2):60-2. PubMed ID: 10832578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a frequent variant in ALG6, the cause of Congenital Disorder of Glycosylation-Ic.
    Westphal V; Xiao M; Kwok PY; Freeze HH
    Hum Mutat; 2003 Nov; 22(5):420-1. PubMed ID: 14517965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DPM2-CDG: a muscular dystrophy-dystroglycanopathy syndrome with severe epilepsy.
    Barone R; Aiello C; Race V; Morava E; Foulquier F; Riemersma M; Passarelli C; Concolino D; Carella M; Santorelli F; Vleugels W; Mercuri E; Garozzo D; Sturiale L; Messina S; Jaeken J; Fiumara A; Wevers RA; Bertini E; Matthijs G; Lefeber DJ
    Ann Neurol; 2012 Oct; 72(4):550-8. PubMed ID: 23109149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel carbohydrate-deficient glycoprotein syndrome characterized by a deficiency in glucosylation of the dolichol-linked oligosaccharide.
    Burda P; Borsig L; de Rijk-van Andel J; Wevers R; Jaeken J; Carchon H; Berger EG; Aebi M
    J Clin Invest; 1998 Aug; 102(4):647-52. PubMed ID: 9710431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Congenital disorder of type Ia protein glycosylation: clinical, biochemical and molecular characteristics in 2 siblings with cerebellar hypoplasia].
    Honzík T; Malonová E; Hansíková H; Rosipal R; Poupĕtová H; Martásek P; Zeman J
    Cas Lek Cesk; 2003; 142(5):276-9. PubMed ID: 12920791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency of dolichol-phosphate-mannose synthase-1 causes congenital disorder of glycosylation type Ie.
    Imbach T; Schenk B; Schollen E; Burda P; Stutz A; Grunewald S; Bailie NM; King MD; Jaeken J; Matthijs G; Berger EG; Aebi M; Hennet T
    J Clin Invest; 2000 Jan; 105(2):233-9. PubMed ID: 10642602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new subtype of a congenital disorder of glycosylation (CDG) with mild clinical manifestations.
    Assmann B; Hackler R; Peters V; Schaefer JR; Arndt T; Mayatepek E; Jaeken J; Hoffmann GF
    Neuropediatrics; 2001 Dec; 32(6):313-8. PubMed ID: 11870587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital disorder of glycosylation type Ia: a clinicopathological report of a newborn infant with cerebellar pathology.
    Aronica E; van Kempen AA; van der Heide M; Poll-The BT; van Slooten HJ; Troost D; Rozemuller-Kwakkel JM
    Acta Neuropathol; 2005 Apr; 109(4):433-42. PubMed ID: 15714316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term evolution of eight Spanish patients with CDG type Ia: typical and atypical manifestations.
    Pérez-Dueñas B; García-Cazorla A; Pineda M; Poo P; Campistol J; Cusí V; Schollen E; Matthijs G; Grunewald S; Briones P; Pérez-Cerdá C; Artuch R; Vilaseca MA
    Eur J Paediatr Neurol; 2009 Sep; 13(5):444-51. PubMed ID: 18948042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and clinical description of the first US patients with congenital disorder of glycosylation Ig.
    Eklund EA; Newell JW; Sun L; Seo NS; Alper G; Willert J; Freeze HH
    Mol Genet Metab; 2005 Jan; 84(1):25-31. PubMed ID: 15639192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital disorder of glycosylation Ic due to a de novo deletion and an hALG-6 mutation.
    Eklund EA; Sun L; Yang SP; Pasion RM; Thorland EC; Freeze HH
    Biochem Biophys Res Commun; 2006 Jan; 339(3):755-60. PubMed ID: 16321363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The T911C (F304S) substitution in the human ALG6 gene is a common polymorphism and not a causal mutation of CDG-Ic.
    Vuillaumier-Barrot S; Le Bizec C; Durand G; Seta N
    J Hum Genet; 2001; 46(9):547-8. PubMed ID: 11558905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficiency of the first mannosylation step in the N-glycosylation pathway causes congenital disorder of glycosylation type Ik.
    Grubenmann CE; Frank CG; Hülsmeier AJ; Schollen E; Matthijs G; Mayatepek E; Berger EG; Aebi M; Hennet T
    Hum Mol Genet; 2004 Mar; 13(5):535-42. PubMed ID: 14709599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurological presentation in pediatric patients with congenital disorders of glycosylation type Ia.
    Miossec-Chauvet E; Mikaeloff Y; Heron D; Merzoug V; Cormier-Daire V; de Lonlay P; Matthijs G; Van Hulle C; Ponsot G; Seta N
    Neuropediatrics; 2003 Feb; 34(1):1-6. PubMed ID: 12690561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A severe human metabolic disease caused by deficiency of the endoplasmatic mannosyltransferase hALG11 leads to congenital disorder of glycosylation-Ip.
    Rind N; Schmeiser V; Thiel C; Absmanner B; Lübbehusen J; Hocks J; Apeshiotis N; Wilichowski E; Lehle L; Körner C
    Hum Mol Genet; 2010 Apr; 19(8):1413-24. PubMed ID: 20080937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe ALG8-CDG (CDG-Ih) associated with homozygosity for two novel missense mutations detected by exome sequencing of candidate genes.
    Sorte H; Mørkrid L; Rødningen O; Kulseth MA; Stray-Pedersen A; Matthijs G; Race V; Houge G; Fiskerstrand T; Bjurulf B; Lyle R; Prescott T
    Eur J Med Genet; 2012 Mar; 55(3):196-202. PubMed ID: 22306853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and molecular features of congenital disorder of glycosylation in patients with type 1 sialotransferrin pattern and diverse ethnic origins.
    Enns GM; Steiner RD; Buist N; Cowan C; Leppig KA; McCracken MF; Westphal V; Freeze HH; O'brien JF; Jaeken J; Matthijs G; Behera S; Hudgins L
    J Pediatr; 2002 Nov; 141(5):695-700. PubMed ID: 12410200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrophobic Man-1-P derivatives correct abnormal glycosylation in Type I congenital disorder of glycosylation fibroblasts.
    Eklund EA; Merbouh N; Ichikawa M; Nishikawa A; Clima JM; Dorman JA; Norberg T; Freeze HH
    Glycobiology; 2005 Nov; 15(11):1084-93. PubMed ID: 16079417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbohydrate deficient glycoprotein syndrome type IV: deficiency of dolichyl-P-Man:Man(5)GlcNAc(2)-PP-dolichyl mannosyltransferase.
    Körner C; Knauer R; Stephani U; Marquardt T; Lehle L; von Figura K
    EMBO J; 1999 Dec; 18(23):6816-22. PubMed ID: 10581255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.